Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy

Stem Cells and Development

Volumn 16, Issue 1, 2007, Pages 177-186

  Lister, John ^a   Gryn, Jeffrey F ^a   McQueen, Karina L ^c   Harris, David T ^b   Rossetti, James M ^a   Shadduck, Richard K ^a  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; CYCLOSPORIN; DACLIZUMAB; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MELPHALAN; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; DEATH; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SURVIVAL TIME; Y CHROMOSOME;

ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; TRANSPLANTATION CONDITIONING;

EID: 33847674983     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.06500-HB     Document Type: Article

References (42)

1. Broxmeyer HE, GW Douglas, G Hangoc, S Cooper, J Bard, D English, M Arny, L Thomas and EA Boyse. (1989). Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828-3832.
2. Gluckman E, HA Broxmeyer, AD Auerbach, HS Friedman, GW Douglas, A Devergie, H Esperou, D Thierry, G Socie, P Lehn, S Cooper, D English, J Kurtzberg, J Bard and EA Boyse. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178.
3. Isoyama K, K Ohnuma, K Kato, TA Takahashi, S Kai, S Kato, M Takanashi, N Sato, H Sato, K Kitajima, T Naoe, H Saito and H Nishihira. (2003). Cord blood transplantation from unrelated donors: a preliminary report from the Japanese Cord Blood Bank Network. Leuk Lymphoma 44:429-438.
4. Laughlin MJ, M Eapen, P Rubinstein, JE Wagner, MJ Zhang, RE Champlin, C Stevens, JN Barker, RP Gale, HM Lazarus, DI Marks, JJ van Rood, A Scaradavou and MM Horowitz. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275.
5. Wagner JE and J Barker. (2004). Umbilical cord blood transplantation after a non-myeloablative therapy in high risk adults. Biol Blood Marrow Transplant 10:733-734.
6. Rocha V, M Labopin, G Sanz, W Arcese, R Schwerdtfeger, A Bosi, N Jacobsen, T Ruutu, M de Lima, J Finke, F Frassoni and E Gluckman. (2004). Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276-2285.
7. Gluckman E, V Rocha, A Boyer-Chammard, F Locatelli, W Arcese, R Pasquini, J Ortega, G Souillet, E Ferreira, JP Laporte, M Fernandez and C Chastang. (1997). Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337:373-381.
8. Harris DT. (1996). Experience in autologous and allogeneic cord blood banking. J Hematother 5:123-128.
9. Harris DT, MJ Schumacher, S Rychlik, A Booth, A Acevedo, P Rubinstein, J Bard and EA Boyse. (1994). Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 13:135-143.
10. Gomez-Lozano N and C Vilches. (2002). Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 59:184-193.
11. Hansasuta P, T Dong, H Thananchai, M Weekes, C Willberg, H Aldemir, S Rowland-Jones and VM Braud. (2004). Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34:1673-1679.
12. Parham P and KL McQueen. (2003). Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nature Rev Immunol 3:108-122.
13. Mathe G, JL Amiel, L Schwarzenberg, A Cattan and M Schneider. (1963). Haematopoietic chimera in man after allogenic (homologous) bone-marrow transplantation. (Control of the secondary syndrome. Specific tolerance due to the chimerism). Br Med J 5373:1633-1635.
14. Mathe G, JL Amiel, L Schwarzenberg, A Cattan, M Schneider, MJ Devries, M Tubiana, C Lalanne, JL Binet, M Papiernik, G Seman, M Matsukura, AM Mery, V Schwarzmann and A Flaisler. (1965). Successful allogenic bone marrow transplantation in man: chimerism, induced spe-cific tolerance and possible anti-leukemic effects. Blood 25:179-196.
15. Barker JN, DJ Weisdorf, TE DeFor, BR Blazar, PB McGlave, JS Miller, CM Verfaillie and JE Wagner. (2005). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:1343-1347.
16. De Lima M, LS St John, ED Wieder, MS Lee, J McMannis, S Karandish, S Giralt, M Beran, D Couriel, M Korbling, S Bibawi, R Champlin and KV Komanduri. (2002). Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 119:773-776.
17. Ende M and N Ende. (1972). Hematopoietic transplantation by means of fetal (cord) blood: a new method. Virginia Medical Monthly (1918) 99:276-280.
18. He JS, H Huang, Z Cai, L Li, XJ Ye, J Zhang, XR Hu, AY Jin and MF Lin. (2003). [Treatment of one case of adult chronic myelogenous leukemia by two units of unrelated umbilical cord blood transplantationl. Zhongguo Shi Yan Xue Ye Xue Za Zhi 11:508-511.
19. Shen BJ, HS Hou, HQ Zhang and XW Sui. (1994). Unrelated, HLA-mismatched multiple human umbilical cord blood transfusion in four cases with advanced solid tumors: initial studies. Blood Cells 20:285-292.
20. Weinreb S, JC Delgado, OP Clavijo, EJ Yunis, L Bayer-Zwirello, L Polansky, L Deluhery, G Cohn, JT Yao, TC Stec, D Higby and C Anderzejewski. (1998). Transplantation of unrelated cord blood cells. Bone Marrow Transplant 22:193-196.
21. Harris DT, J LoCascio and FJ Besencon. (1994). Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant 14:545-553.
22. + stem cell transplantation in children: comparison with bone marrow transplantation. Int J Hematol 77:399-407.
23. Berger M, E Vassallo, F Nesi, C Venturi, E Madon and F Fagioli. (2004). Successful unrelated cord blood transplantation following reduced-intensity conditioning for refractory acute myeloid leukemia. J Pediatr Hematol Oncol 26:98-100.
24. Del Toro G, P Satwani, L Harrison, YK Cheung, M Brigid Bradley, D George, DJ Yamashiro, J Garvin, D Skerrett, O Bessmertny, K Wolownik, C Wischhover, C van de Ven and MS Cairo. (2004). A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 33:613-622.
25. Ildstad ST and DH Sachs. (1984). Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168-170.
26. Gluckman E. (2004). Ex vivo expansion of cord blood cells. Exp Hematol 32:410-412.
27. Shpall EJ, IK McNiece, M De Lima, JD McMannis, S Robinson, T Peled and RE Champlin. (2004). Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 10:738.
28. Wall DA. (2005). Issues in the quality of umbilical cord blood stem cells for transplantation: challenges in cord blood banking quality management. Transfusion 45:826-828.
29. + cell yield for cord blood banking. Transfusion 44:262-267.
30. Wagner JE, JN Barker, TE DeFor, KS Baker, BR Blazar, C Eide, A Goldman, J Kersey, W Krivit, ML MacMillan, PJ Orchard, C Peters, DJ Weisdorf, NK Ramsay and SM Davies. (2002). Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618.
31. Giralt S, PF Thall, I Khouri, X Wang, 1 Braunschweig, C Ippolitti, D Claxton, M Donato, J Bruton, A Cohen, M Davis, BS Andersson, P Anderlini, J Gajewski, S Kornblau, M Andreeff, D Przepiorka, NT Ueno, J Molldrem and R Champlin. (2001). Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 97:631-637.
32. Cooke KR and G Yanik. (2004). Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 34:753-765.
33. Barker JN, DJ Weisdorf, TE DeFor, BR Blazar, JS Miller and JE Wagner. (2003). Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102:1915-1919.
34. Wagner JE and J Barker. (2004). Umbilical cord blood transplantation: Novel approaches toward improving engraftment. Biol Blood Marrow Transplant 10:733.
35. Giebel S, F Locatelli, T Lamparelli, A Velardi, S Davies, G Frumento, R Maccario, F Bonetti, J Wojnar, M Martinetti, F Frassoni, G Giorgiani, A Bacigalupo and J Holowiecki. (2003). Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102:814-819.
36. Xu R, WY Yan, XF Jiang, SM Xie, N Zhu, FH Kong and XT Pei. (2004). [Prediction of acute GVHD after umbilical cord blood transplantation by HLA three-dimensional structure matching]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12:282-286.
37. Chao NJ. (2004). Minors come of age: Minor histocompatibility antigens and graft-versus-host disease. Biol Blood Marrow Transplant 10:215-223.
38. Laylor R, L Cannella, E Simpson and F Dazzi. (2004). Minor histocompatibility antigens and stem cell transplantation. Vox Sang 87 (Suppl 2):11-14.
39. Goulmy E. (2004). Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy. Cancer J 10:1-7.
40. Falkenburg JH, L van de Corput, EW Marijt and R Willemze. (2003). Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol 31:743-751.
41. Roopenian D, EY Choi and A Brown. (2002). The immunogenomics of minor histocompatibility antigens. Immunol Rev 190:86-94.
42. Simpson E, D Scott, E James, G Lombardi, K Cwynarski, F Dazzi, M Millrain and PJ Dyson. (2002). Minor H antigens: genes and peptides. Transpl Immunol 10:115-123.